BioLab Holdings Launches EmeraNova™ to Advance the Future of Tissue Restoration
Expanded vision reflects focus beyond wound care to advancing innovation across the full tissue restoration journey PHOENIX — BioLab Holdings announced today a new, larger mission with the launch of EmeraNova™, a new cor
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.